Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Intermediate and posterior uveitis.

John V Forrester1

  • 1Department of Ophthalmology, University of Aberdeen Medical School, Aberdeen, UK.

Chemical Immunology and Allergy
|February 1, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Myeloid Cell Protein Tyrosine Phosphatase 1B Drives Retinal Neurodegeneration in Diabetic Mice.

Diabetes·2026
Same author

Infection control in the brain and the eye.

Acta ophthalmologica·2026
Same author

Antigen-specific polyfunctional cytotoxic T cells differentiate intraocular from peripheral blood immune responses in posterior uveitis.

Clinical & translational immunology·2025
Same author

Protocol for isolating and characterizing human vitreous immune cell infiltrates by flow cytometry and single-cell transcriptomic studies.

STAR protocols·2025
Same author

Evolution of the ocular immune system.

Eye (London, England)·2024
Same author

Immune Privilege Furnishes a Niche for Latent Infection.

Frontiers in ophthalmology·2024
Same journal

Educational programmes in food allergy.

Chemical immunology and allergy·2015
Same journal

Prevention of food allergy.

Chemical immunology and allergy·2015
Same journal

The effects of food allergy on quality of life.

Chemical immunology and allergy·2015
Same journal

Worldwide food allergy labeling and detection of allergens in processed foods.

Chemical immunology and allergy·2015
Same journal

Food allergy: psychosocial impact and public policy implications.

Chemical immunology and allergy·2015
Same journal

Nutritional aspects and diets in food allergy.

Chemical immunology and allergy·2015
See all related articles

Posterior uveitis, an eye inflammation, can cause vision loss, particularly when affecting the macula. Research into its mechanisms has led to new biologic and cell-based therapies for tailored treatment.

Area of Science:

  • Ophthalmology
  • Immunology
  • Retinal Diseases

Background:

  • Posterior uveitis involves sight-threatening inflammation in the eye's posterior segment, potentially affecting the retina, retinal vessels, and optic nerve.
  • Macular edema is a common complication, leading to significant visual loss in patients with posterior uveitis.
  • Understanding the immune mechanisms is crucial for developing effective treatments for this condition.

Purpose of the Study:

  • To elucidate the mechanisms of inflammatory cell damage in experimental models of posterior uveitis.
  • To investigate the disruption of immune privilege in the posterior segment of the eye.
  • To inform the development of novel therapeutic strategies for posterior uveitis.

Main Methods:

  • Utilized experimental models of posterior uveitis.

Related Experiment Videos

  • Employed transgenic and gene deletion models to study inflammation.
  • Investigated the roles of CD4 T cells, effector macrophages, and pro-inflammatory cytokines.

    • Main Results:

    • Identified key inflammatory cells (CD4 T cells, macrophages) and cytokines involved in retinal damage.
    • Demonstrated how immune privilege in the posterior eye segment is compromised during inflammation.
    • Provided insights into the cellular and molecular pathways driving posterior uveitis.

    Conclusions:

    • Experimental models have significantly advanced our understanding of posterior uveitis pathogenesis.
    • This knowledge has facilitated the development of novel immunosuppressants and biologics.
    • Future cell-based therapies hold promise for personalized treatment of posterior uveitis.